Triamterene and Hydrochlorothiazide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals, Inc.. The primary component is Triamterene; Hydrochlorothiazide.
| Product ID | 68788-9792_d8fc529b-9e8c-452f-901e-ead95fac09b8 |
| NDC | 68788-9792 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Triamterene and Hydrochlorothiazide |
| Generic Name | Triamterene And Hydrochlorothiazide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-04-30 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA071851 |
| Labeler Name | Preferred Pharmaceuticals, Inc. |
| Substance Name | TRIAMTERENE; HYDROCHLOROTHIAZIDE |
| Active Ingredient Strength | 75 mg/1; mg/1 |
| Pharm Classes | Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2012-04-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA071851 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-04-30 |
| Marketing End Date | 2019-11-14 |
| Marketing Category | ANDA |
| Application Number | ANDA071851 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-04-30 |
| Marketing End Date | 2019-11-14 |
| Marketing Category | ANDA |
| Application Number | ANDA071851 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-04-30 |
| Marketing End Date | 2019-11-14 |
| Marketing Category | ANDA |
| Application Number | ANDA071851 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-04-30 |
| Marketing End Date | 2019-11-14 |
| Ingredient | Strength |
|---|---|
| TRIAMTERENE | 75 mg/1 |
| SPL SET ID: | b2d1fc09-f8f9-42d7-ae95-b447509062d9 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |